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Abstract 
Background 
The management of rheumatoid arthritis (RA) usually entails regular hospital reviews with a 
specialist often when the patient is well rather than during a period of exacerbation. An 
alternative approach where patients initiate appointments when they need them can 
improve patient satisfaction and resource use whilst being safe. This service evaluation 
reports a system wide implementation of a patient-initiated review appointment system 
called Direct Access (DA) for people with RA. The aim was to establish the impact on patient 
satisfaction of the new system versus usual care as well as evaluate the implementation 
processes. 
Method 
As all patients could not start on the new system at once, in order to manage the 
implementation, patients were randomly allocated to DA or to usual care. Instead of regular 
follow-up appointments, DA comprised an education session and access to a nurse-led 
telephone advice line where appointments could be accessed within two weeks. Usual care 
comprised routine follow-ups with the specialist. Data were collected on patient 
satisfaction, service use and outcomes of any contact to the advice line.  
Results 
Three hundred and eleven patients with RA were assessed as being suitable for DA. In terms 
of patient satisfaction, between-group differences were found in favour of DA for 
accessibility and convenience, ease of contacting the nurse and overall satisfaction with the 
service. Self-reported visits to the GP were also significantly lower. DA resulted in a greater 
number of telephone contacts (incidence rate ratio = 1.69; 95% CI 1.07 to 2.68). Hospital 
costs of the two different service models were similar. Mean waiting time for an 
appointment was 10.8 days 
Conclusion 
This service evaluation found that DA could be implemented and demonstrated patient 
benefit in a real world setting. Further research establishing the broader cost-consequences 
across the whole patient pathway would add to our findings.   
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Introduction 
Rheumatoid arthritis (RA) is a long-term condition that primarily affects the synovial joints causing 
unpredictable episodes of joint pain, stiffness and swelling. There are approximately 580,000 people 
with RA in the United Kingdom (UK), with a global prevalence of 0.24% (1). It has been estimated 
that the overall cost of RA to the UK economy is £8 billion per year due to loss of productivity (2). 
People with RA often have lifelong symptoms that fluctuate daily, intermittent disease flares, and an 
unpredictable long-term outcome. This variation in experience makes it important for patients to 
develop the skills to manage their own condition and its consequences on their lives (3). 
International recommendations state that people with stable RA should be reviewed every three to 
six months (4). Since patients are often seen on a date determined some time in advance, and 
review may occur when the patient is well rather than during periods of exacerbation (3), this 
traditional system of review may lead to a mismatch between patient need and clinical input. 
Although NICE recommends a minimum annual review, with access to additional specialist support 
for flares the burden of routine appointments can make it difficult to accommodate urgent care 
needs (5). A previous study into the content of routine reviews of patients with RA reported 42% 
were thought by a rheumatologist to be unnecessary (6). These findings suggest, first, that 
considerable hospital out-patient time and resources are wasted and, second, that the systems of 
review may be unresponsive at the times when patients need them most.  
There is evidence to support an alternative model of RA management. A randomised controlled trial 
(RCT) compared standard rheumatologist-initiated review at three- to six-month intervals with 
patient-initiated review alone (7). The authors found that patient-initiated reviews maintained the 
patient’s physical and psychological status but reduced unnecessary medical reviews by at least a 
third, thus making more efficient use of finite resources. The trial data also indicated that patients 
and primary-care physicians had more confidence and satisfaction in the new system compared with 
the standard model of routine follow-up. Two recent systematic reviews (8, 9) of patient-initiated 
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clinics for those with long-term conditions reported this was a safe approach, with some health 
service resource savings, and greater patient and clinician satisfaction.  
This paper reports the outcomes from a project intended to implement a patient-initiated review 
system for RA at Plymouth Hospitals NHS Trust (PHNT) in the UK. Prior to the start of the project the 
PHNT had a clinician-driven follow-up system for people with RA – one which was overwhelmed and 
subject to delays. This study aimed to (a) establish the impact of a patient-initiated review system, 
called Direct Access (DA) for people with RA compared with usual follow-up on patient satisfaction 
and service use, and (b) to evaluate the implementation processes.  
Methods 
Study design 
A prospective service evaluation, comparing DA with usual care was undertaken at PHNT from 
February 2012 to October 2013. 
Population 
People with RA aged 18 years or over, who had had RA for more than two years, and who were able 
to initiate telephone contact if needed were deemed eligible. We excluded people if they had no 
access to a telephone or were thought unable themselves or through a relative or friend to initiate 
telephone contact via the advice line when their condition required clinical review.  
Allocation and recruitment 
Three rheumatologists identified potentially eligible patients. Patients attending routine clinical 
review were then confirmed for suitability for the new system and were randomised to either DA or 
to usual care. We chose to randomise for two reasons; firstly due to the finite capacity of the 
education sessions (see below) meaning that all patients would not be able to enrol in DA at once, 
and secondly, it enabled the opportunity to undertake a prospective, comparative evaluation of DA 
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with the traditional clinician-led follow up model. The randomisation schedule was generated 
independently of the clinical and administrative team using computer generated random numbers. 
Any patients that declined to participate in the new system or did not attend an education session 
continued to receive their usual clinical care and regular reviews and were not included in the 
evaluation. As this was a service evaluation, ethical approval was not required and patients did not 
have to provide informed consent to take part. This was confirmed by the National Research Ethics 
Service South West (Bristol). 
Interventions 
Direct Access 
Those allocated to the DA review system were sent an initial information sheet in the post by the 
administrative team explaining the system and offered a choice of dates to attend a patient 
education session. The patient education sessions were staggered over nine months due to limited 
departmental resources and were led by a rheumatology specialist nurse and involved groups of 
eight people with RA. The sessions focused on issues such as the operation of the new system, what 
patients can expect, when and how to call the advice line, when and how to ask for appointments. 
Patients were also able to raise any other queries they had regarding the system (3). Patients 
allocated to DA were not offered routine clinical reviews; their family doctor was informed of this 
and sent guidelines about how to manage problems commonly experienced by people with 
established RA. Patients or their family doctor could arrange prompt clinical advice and a review in 
clinic where required by calling a rheumatology nurse-led advice line where appointments could be 
accessed within two working weeks.  
Usual Care 
Those people allocated to the control arm of the study continued to receive usual care in the form of 
planned appointments at regular intervals for a year before transferring to the new system.   
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Patients allocated to DA or usual care who had not contacted the advice line or been seen by either 
the consultant or nurse after a year were contacted for a clinical review with the rheumatology 
nurse specialist. This acted as a safety net (9). 
Data collection 
The primary outcome was patient satisfaction at twelve months, with secondary outcomes being 
service use and associated costs. We chose patient satisfaction as a surrogate measure of service 
quality. Process measures were also collected. Baseline demographic data were collected (age, 
gender, disease duration). We planned to collect the following clinical data at baseline and twelve 
months: total and swollen joint counts, early morning stiffness, pain in previous 24 hours, disease 
duration, disease activity score (DAS-CRP), Health Assessment questionnaire, patient and clinician 
global opinion of disease activity, C-reactive protein, plasma viscosity, haemoglobin, rheumatoid 
factor and rheumatoid factor titre (10). However, it quickly became clear that this was not going to 
be feasible within current clinical resources and was therefore abandoned.  
Patient satisfaction 
Patient satisfaction data were collected twelve months following randomisation using the Short-
form Patient Satisfaction Questionnaire (PSQ-18) (11). The PSQ-18 comprises seven different 
subscales: general satisfaction, technical quality, interpersonal manner, communication, financial 
aspects, time spent with doctor, accessibility and convenience. Individual items were recorded on a 
five point Likert scale with ‘1’ indicating strong agreement with statement and ‘5’ indicating strong 
disagreement. Scoring on the sub-scales was calculated so that higher scores indicated satisfaction 
with medical care. After scoring, the median (interquartile range-IQR) scores of items within the 
same subscale were calculated. Five additional questions specifically relating to the local service 
satisfaction were also included: (a) ease of access to appointment with consultant, (b) ease of 
contacting specialist nurse by telephone, (c) satisfaction with telephone support, (d) satisfaction 
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with frequency of reviews, (e) satisfaction with own involvement in deciding frequency of reviews. 
The questions were scored using the same Likert scale that was used for the PSQ-18. The responses 
to the additional five questions were dichotomised and reported as a percentage. This was 
undertaken by grouping together (i) the two categories that indicated a favourable situation (i.e. 
satisfaction) and (ii) the three categories that indicated dissatisfaction or indifference.  For the 
positively-worded questions this meant combining the “strongly agree” and “agree” categories 
but for one negatively-worded question it meant combining the “strongly disagree” and 
“disagree” categories. Patients were also asked to indicate their satisfaction with overall 
rheumatology care on a scale from 0 (completely unsatisfied) to 100 (completely satisfied). 
Satisfaction data were collected by a rheumatology healthcare assistant over the telephone. 
Service use 
Hospital patient administration systems were used to collect data on number of contacts to the 
nurse-led telephone advice line and face-to-face contacts with the rheumatologist or nurse specialist 
over the twelve-month period following randomisation.  Patients were asked to report the number 
of times they saw their general practitioner regarding their RA during the previous year. 
Process measures 
Process measures for DA included the outcome of phoning the advice line and whether a face-to-
face appointment was needed and, if so, who this was with (rheumatologist or nurse specialist). The 
duration between phoning the advice line and having a face-to-face appointment was also recorded. 
The review systems were monitored to ascertain whether they were undertaken as planned.  
Sample size 
The assumptions underlying the sample size calculation were derived from a published RCT (12). The 
current evaluation required 190 subjects followed up for a period of 12 months in each of the DA 
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and usual care groups in order to detect a decrease in the number of consultations from 2.5 per year 
to 2 per year with 90% power at the 5% level of significance level. 
 
Analysis 
A CONSORT flow chart was used to describe the flow of patients in the study (Figure 1). Descriptive 
statistics were used to report the characteristics of patients allocated to each study arm. The Mann 
Whitney test was used to compare quantitative outcomes between the DA and usual care groups 
and the Chi-squared test to compare binary outcomes. The median (interquartile range - IQR) was 
calculated for number of GP visits and overall satisfaction.  
The occurrence of telephone and face-to-face contacts was compared between the DA and usual 
care groups using Poisson regression to analyse the number of contacts over 12 months. The rate of 
contact (based on the total number of contacts and person-years of patient follow-up) was reported 
for each group together with the incidence rate ratio (IRR), 95% confidence interval and p-value. 
For those allocated to the intervention, the mean (SD) waiting time from telephone contact to face-
to-face appointment was calculated, and the proportion of people being seen within the target of 
two working weeks. 
Costs, from a secondary care perspective, of delivering DA and usual care were estimated on a per 
participant basis and reported descriptively. During the 12 month follow-up period, individual level 
data were identified from hospital records on: i) the number of telephone contacts with a 
rheumatology nurse; ii) the number of face-to-face contacts with a rheumatology nurse and; iii) the 
number of face-to-face contacts with a consultant rheumatologist. The length of time of telephone 
calls and face-to-face contacts was estimated via discussion with clinical staff. In addition, the 
resource requirements for the education sessions were also determined by discussion with clinical 
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staff. Nationally-recognised unit costs (13), as set-out in Table 1, were applied to the estimated 
service use. 
**Table 1** 
Results 
Figure 1 shows the patient flow through the study. One hundred and fifty six patients were allocated 
to DA with 155 allocated to usual care. Four patients that had been allocated to DA were assessed as 
being clinically unsuitable to continue during follow-up resulting in a need to resume regular clinical 
reviews. The mean age (SD) of DA and usual care participants was 65.4 (11.7) and 63.1 (13.1) 
respectively. One hundred and four DA patients were female (75.4%) as were 118 (76.6%) of usual 
care participants.  
**Figure 1** 
Patient satisfaction questionnaire data were available from 80/138 (58%) of intervention arm 
patients and from 98/155 (64%) of control arm participants at one year follow-up (Table 2). 
Between-group differences were found in favour of DA for accessibility and convenience, ease of 
contacting specialist nurse and overall satisfaction with the service. Interpersonal manner was 
significantly higher for usual care.  There were no between-group differences in other aspects of 
patient satisfaction. In terms of service use (Table 3), self-reported visits to GP were significantly 
lower for DA participants when compared with usual care (median 0 and 1, respectively; p = 0.03). 
There was evidence of an increase in telephone contacts by those using DA (IRR = 1.69; 95% CI 1.07, 
2.68). There was no significant difference in the number of hospital based face-to-face consultations 
(IRR = 0.92; 95% CI 0.70, 1.20) although a smaller proportion of DA consultations were with a 
rheumatologist when compared with usual care consultations (59% vs. 79%).  
**Table 2** 
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**Table 3** 
After contacting the advice line 44/46 (96%) patients required a face-to-face appointment. Of those 
intervention group patients needing a face-to-face appointment 91% (40/44) were seen within 14 
calendar days (10 working days). The mean (SD) waiting time from telephone contact to face-to-face 
appointment was 10.8 (10.3) days, ranging from being seen the same day to waiting for 70 days. 
Median (IQR) waiting time was 10 (7 to 13) days.  
The resource use and costs of the two models of service delivery are presented in Table 4. This 
indicates the different patterns of resource use, and shows a greater cost of telephone contacts and 
face-to-face appointments with the rheumatology nurse in the intervention group, and a greater 
cost of face-to-face appointment with the rheumatology consultant in the control group. When the 
cost of the educational session was added, the total cost of service delivery by both models was 
broadly similar.  
**Table 4** 
Discussion 
This study aimed to evaluate the implementation of a patient-initiated review system, known as 
Direct Access, for people with rheumatoid arthritis. For most subscales of the PSQ-18 there were no 
statistical significant differences between DA and usual care unlike the findings of from Whear and 
colleagues (8). The different findings may relate to the varied ways in which satisfaction is 
conceptualised and measured. There was, however, a significant difference in favour of DA with 
relation to PSQ-18 sub-scale for accessibility and convenience, ease of contacting the nurse specialist 
and overall satisfaction. The issue of accessibility is supported by the findings of the nested 
qualitative study that took place in parallel to this evaluation (14) that found that being able to 
access the service when they needed, rather than when they were well was a better use of patients 
and staff time. Being in control of accessing care when needed is important to people with long term 
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conditions (15) and recent discussions with our local population with RA and other long-term 
conditions highlighted that they want more accessible and responsive services to meet their needs 
in a timely, effective and efficient way. We also found a difference, in terms of interpersonal 
manner, in favour of usual care. The reasons for this are unclear as it was the same clinical team 
seeing the patients.  
No difference in terms of secondary care service use was found which is in contrast to Hewlett and 
colleagues who reported 44% fewer reviews with the consultant for those using a patient-initiated 
service (7). However, we reported that those who remained on the usual care pathway were seen, 
on average only 0.73 times per year; considerably lower than the 2.5 appointments per year that 
had been estimated based on previous research (7), whereas those using DA were seen on average 
only 0.6 times in a year. This reduction in usual care provision was due in part to reduced staffing 
and an increasing waiting list, and because NHS priorities are for seeing people for the initial 
appointment (16) with no targets around follow-up, thus rendering follow-up appointments less of a 
priority. We found no evidence of ‘overuse’ of DA, with the largest number of contacts from a single 
patient being three over the course of a year. This challenges the view that this type of appointment 
would need to be capped (17). An unexpected finding of our study was the significant reduction in 
patient-reported visits to the GP, as there had been concern amongst the clinicians that there could 
potentially be a shift towards an increased primary care burden. We found broadly similar costs for 
DA and usual care although these could be viewed as conservative as usual care participants had not 
received the number of anticipated appointments. There may well be potential cost savings by 
implementing a patient-initiated review system in services that currently see patients more 
frequently than the 0.73 times a year we observed. The main cost drivers of the different models are 
set out here, but we did not take into account potential broader costs, such as contacts with other 
healthcare professionals e.g., physiotherapists, or other costs such as prescribing, hospital 
admissions or community-based health or social care provision. The collection of such data may 
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have given added value to the findings but its collection was unsustainable within existing 
overstretched clinical services. 
Only 9% of patients were not seen within two weeks of contacting the advice line. The reasons for 
this include the patient preferring to delay and see their usual specialist, and public holidays 
resulting in fewer clinic slots available those weeks. Advance clinic planning is essential for those 
times where additional capacity is needed to avoid the system breaking down (18). 
A further difference observed in the different service delivery models was the type of follow-up with 
a greater proportion of people requiring specialist review being seen by a nurse rather than a 
rheumatologist. The increased autonomy and clinical skills, such as independent prescribing, of the 
nursing profession in the UK has seen a shift in the skill mix of service provision with non-medical 
health professionals undertaking roles that had traditionally been undertaken by physicians (19).  
A number of limitations were noted that related to methods, data collection and intervention 
delivery. The first limitation was the failure to recruit the sample size within the time frame of the 
evaluation. This was due to the practical challenge of identifying potentially suitable participants 
during routine clinical practice rather than a lack of potential participants. Secondly, there is 
uncertainty whether the participants in the two study arms were similar at baseline in terms of 
clinical characteristics, due to extensive missing data. This is the challenge of undertaking a formal 
evaluation of clinical practice and service delivery without additional data collection resources. 
However, the two groups appear broadly similar in terms of gender and age and the nature of the 
randomisation process should potentially mitigate this limitation. Future evaluations should utilise 
other approaches to maximise patient-reported data collection, use routine electronic disease 
assessment data, and consideration should be made to the quantity and type of outcome data 
collected. Fewer clinical and symptom measures and a focus on what outcomes are important to 
patients (20), such as quality of life, should be considered in any future evaluations (21). We are 
currently developing a toolkit for implementing DA with other patient groups and one key area is 
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selecting outcomes that are important to those patients that can be collected in a sustainable way as 
a routine part of the service. A third limitation was that low staffing levels impacted on the ability to 
review patients at the safety net appointment at twelve months. The safety net is important for 
those not able to recognise changes in disease state that may require clinical intervention such as 
those with cognitive impairment or depression. However, DA education should, where possible, 
ensure that a family member or friend attend the education session and act as an advocate so they 
know how and when to access the service. For some though this may not be possible and therefore 
DA may not be appropriate as significant deterioration may occur and go unreported. Despite the 
limitations, we undertook an evaluation within a real world setting, experiencing the challenges of 
undertaking an evaluation without the traditional structures of a formal research study. We were 
able to undertake a prospective, comparative study using randomisation which has provided 
valuable information for future the implementation of patient-initiated reviews.  
After a clinical department review there is now a face-to-face review at eighteen months alongside a 
letter sent to patients that have not been seen for a year. This, however, is contrary to the annual 
review recommended by NICE (5) but is a pragmatic response to freeing clinical capacity whilst 
maintaining reasonable contact with an individual patient.  Notably, there is evidence from the work 
in Bristol that patient-initiated follow-up is not detrimental to clinical or psychological outcomes 
when compared with clinician-initiated care, even after six years (12).  
Conclusion 
This evaluation of implementing research into practice in terms of a patient-initiated review service 
for people with rheumatoid arthritis was found to have benefits over a traditional regular review in 
terms of convenience and accessibility, ease of contacting a nurse specialist and reduced GP 
appointments. In terms of cost, the service was similar to a routine follow-up service. However, 
further evaluation including broader cost-consequences analysis across the whole patient pathway 
would add to the current findings as would a longer follow-up. This evaluation is contributing to the 
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development of a toolkit for supporting the implementation of patient-initiated reviews in other 
specialities and patient groups.  
Acknowledgements  
We would like to thank the Rheumatology team and patients from Plymouth Hospitals NHS Trust.  
This research was funded by the National Institute for Health Research (NIHR) Collaboration for 
Leadership in Applied Health Research and Care South West Peninsula. The views expressed are 
those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.  
Implementation of patient-initiated reviews 
15 
 
References 
1. Cross M, Smith E, Hoy D, et al. The global burden of rheumatoid arthritis: estimates from the 
global burden of disease 2010 study. Ann Rheum Dis. 2014 Jul;73(7):1316-22. 
2. National Rheumatoid Arthritis Society. The economic burden of rheumatoid arthritis. 
Maidenhead, UK2010. 
3. Pope D, Tipler S, Kirwan J, Hewlett S. Implementing a patient-led service for chronic 
conditions. Nurs Times. 2005;101:28 - 31. 
4. Smolen JS, Aletaha D, Bijlsma JW, et al. Treating rheumatoid arthritis to target: 
recommendations of an international task force. Ann Rheum Dis. 2010 Apr;69(4):631-7. 
5. National Institute for Health and Care Excellence. Quality Standard (QS33): Rheumatoid 
arthritis Manchester: NICE,2013. 
6. Hehir M, Hewlett S, Mitchell K, Kirwan J, Memel D, Pollock J, Bennett B. What happens in 
rheumatoid arthritis (RA) out-patient clinics? Rheumatology. 2001;40(S1):S140. 
7. Hewlett S, Mitchell K, Haynes J, Paine T, Korendowych E, Kirwan J. Patient-initiated hospital 
follow-up for rheumatoid arthritis. Rheumatology. 2000;39:990 - 7. 
8. Whear R, Abdul-Rahman A-K, Thompson-Coon J, Boddy K, Perry M, Stein K. Patient initiated 
clinics for patients with chronic or recurrent conditions managed in secondary care: a systematic 
review of patient reported outcomes and patient and clinician satisfaction. BMC Health Services 
Research. 2013;13(1):501. 
9. Whear R, Abdul-Rahman AK, Boddy K, Thompson-Coon J, Perry M, Stein K. The clinical 
effectiveness of patient initiated clinics for patients with chronic or recurrent conditions managed in 
secondary care: a systematic review. PLoS One. 2013;8(10):e74774. 
10. Paudyal P, Perry M, Child S, Gericke C. Evaluation of a patient-initiated review system in 
rheumatoid arthritis: an implementation trial protocol. BMC Musculoskeletal Disorders. 
2012;13(1):120. 
11. Marshall G, Hays R. The patient satisfaction questionnaire short form (PSQ-18). Santa 
Monica: RAND Corporation1994. 
12. Hewlett S, Kirwan J, Pollock J, Mitchell K, Hehir M, Blair P, Memel D, Perry M. Hospital follow 
up in chronic disease: A randomised controlled trial of routine out-patient follow-up versus patient-
initiated direct access in rheumatoid arthritis, extended to 6 years. BMJ. 2005;330(7484):171 - 5. 
13. Curtis L. Unit costs of health and social care. Canterbury: University of Kent2013. 
14. Child S, Goodwin VA, Perry MG, Gericke CA, Byng R. Implementing a patient-initiated review 
system in rheumatoid arthritis: a qualitative evaluation. BMC Health Serv Res. 2015;15:157. 
15. Foot C, Gilburt H, Dunn P, Jabbal J, Seale B, Goodrich J, Buck D, Taylor J. People in control of 
their own health and care: the state of involvement London: The King's Fund2014. 
16. Department of Health. 2014/15 Choice Framework. In: NHS and Finance Directorate, editor.: 
Department of Health; 2014. 
17. Bukhari M, Bamji AN, Deighton C. Is it ever appropriate to discharge patients with 
rheumatoid arthritis? Rheumatology. 2007 November 1, 2007;46(11):1631-3. 
18. Gupta D, Denton B. Appointment sceduling in health care: challenges and opportunities. IIE 
Transactions. 2008;40:800-18. 
19. Kinley H, Czoski-Murray C, George S, et al. Extended scope of nursing practice: a multicentre 
randomised controlled trial of appropriately trained nurses and pre-registration house officers in 
pre-operative assessment in elective general surgery. Health Technol Assess. 2001;5(20):1-87. 
20. Sanderson T, Morris M, Calnan M, Richards P, Hewlett S, Ph DsfARC. What outcomes from 
pharmacological treatments are important to people with rheumatoid arthritis? Creating the basis of 
a patient core set. Arthritis care & research. 2010;62(5):640-6. 
21. Deshpande PR, Rajan S, Sudeepthi BL, Abdul Nazir CP. Patient-reported outcomes: A new era 
in clinical research. Perspectives in Clinical Research. 2011 Oct-Dec;2(4):137-44. 
 
Implementation of patient-initiated reviews 
16 
 
 
Figure legends 
Figure 1 Flow chart of participants though the evaluation 
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Table 1 Unit costs  
Resource use 
item 
Unit cost 
(£, 2012/2013) 
Source Basis of estimate 
Educational 
session (per 
participant) 
£8.94 Personal Social 
Services Research 
Unit (PSSRU) 
1 hour group (8 participants) educational 
session with a Band 7 nurse manager 
(plus 5 hours development time) 
Telephone 
contact 
£8.17 PSSRU 10 minute telephone conversation with 
a Band 6 nurse team leader 
Nurse 
appointment 
£16.33 PSSRU 20 minute face to face appointment with 
a Band 6 nurse team leader 
Consultant 
appointment 
£46.33 PSSRU 20 minute face to face appointment with 
a medical consultant 
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Table 2 Patient satisfaction at one-year follow-up 
Outcome Direct Access 
Median (IQR) 
N=80 
Usual care 
Median (IQR) 
N=98 
p-value 
Patient Satisfaction Questionnaire 
(PSQ-18) Sub-scales 
 
General Satisfaction 4 (4 to 4) 4 (3 to 4) 0.79 
Technical Quality 4 (4 to 4) 4 (3.5 to 4.25) 0.73 
 Interpersonal Manner 4 (4 to 4) 4 (4 to 4.5) 0.01 
Communication 4 (4 to 4) 4 (4 to 4.5) 0.23 
Financial Aspects 4 (4 to 4.5) 4 (4 to 4.5) 0.11 
Time Spent with Doctor 4 (4 to 4) 4 (3.5 to 4.5) 0.38 
Accessibility and Convenience 3.75 (3.5 to 4) 3.5 (3 to 4) 0.02 
Satisfaction with local service  
Found it easy to get appointment 
with doctor, % 
67% 54% 0.07 
Did not find it difficult to contact 
specialist nurse, % 
63% 46% 0.03 
Satisfied with telephone support 
received, % 
67% 56% 0.12 
Satisfied with how often reviewed, 
% 
72% 66% 0.38 
Satisfied with amount of personal 
involvement in deciding frequency 
of review, % 
61% 53% 0.28 
Satisfied with service (100mm visual 
analogue scale) 
100 (80 to 100) 80 (70 to 100) 0.002 
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Table 3 Description of service use over a year 
 Direct Access  
N = 138 
Usual care 
N = 152 
Number of GP visits, median 
(IQR)  
0 (0 to 2) 1 (0 to 3) 
Number of patients/advocates 
contacting nurse advice line (%) 
36 (26%) 30 (20%) 
Total number of phone 
contacts to nurse advice line 
46 30 
Number of patients having 
face-to-face consultation (%) 
78 (47%) 102 (67%) 
Total number of face-to-face 
consultations 
94 113 
-Doctor 55 89 
-Nurse 39 24 
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Table 4 Description of resource use and costs of delivering Direct Access and Usual Care 
 Mean (SD) number of contacts 
per participant 
Mean (SD) cost (£) 
per participant 
 DA 
N=138 
Usual care 
N=152 
DA 
N=138 
Usual care 
N=152 
Educational 
session 
1 - 8.94  
Telephone 
contacts 
0.33 (0.63) 
 
0.20 (0.40) 
 
2.72 (5.16) 
 
1.61 (3.26) 
 
Face-to-face nurse 
appointments 
0.28 (0.45) 
 
0.15 (0.38) 
 
4.61 (7.37) 
 
2.57 (6.25) 
 
Face-to-face 
consultant 
appointments 
0.40 (0.68) 
 
0.61 (0.55) 
 
18.45 (31.42) 
 
28.02 (25.64) 
 
Total cost   34.72 (34.51) 
 
32.21 (22.15) 
 
 
